Search for: "JANSSEN PHARMACEUTICALS, INC. " Results 61 - 80 of 226
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Mar 2018, 7:20 am by Law Offices of Jeffrey S. Glassman
Janssen Pharmaceuticals Inc., et al was reversed in January in state court, specifically the Philadelphia Court of Common Pleas. [read post]
13 Mar 2018, 7:20 am by Law Offices of Jeffrey S. Glassman
Janssen Pharmaceuticals Inc., et al was reversed in January in state court, specifically the Philadelphia Court of Common Pleas. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets. [read post]
24 Nov 2014, 2:15 pm by Tom Lamb
Recently Revised Topamax Label Includes Data Of 2014 Annual Report From The North American Antiepileptic Drug (NAAED) Pregnancy Registry (Posted by Tom Lamb at DrugInjuryWatch.com) By means of an October 21, 2014 FDA letter to Janssen Pharmaceuticals, Inc. [read post]
25 Jan 2025, 10:20 am by Rose Hughes
These foundational principles set the stage for the recent shifts seen in Janssen Pharmaceuticals and 10x Genomics.Judges' Logic and AnalysisIn Janssen Pharmaceuticals v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
8 Sep 2015, 1:15 pm by Tom Lamb
Given these numerous case reports made to Health Canada and documented in medical articles, one wonders whether the responsible drug company, Janssen Pharmaceuticals, Inc., should increase the drug label warnings about hepatic / liver side effects such as acute liver failure, which can be fatal in some instances. [read post]
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
28 Feb 2014, 9:27 pm by Legal Reader
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]